Skip to main content

Table 9 Characteristics of patients with LM after the treatment of alectinib n = 9

From: Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases—a multicenter retrospective study

CNS-related symptoms

n = 0

ECOG

 

 0–1

 ≥ 2

n = 1

n = 8

Number of patients needed mannitol or corticosteroids

n = 0

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us